Product Information
OFLOXACIN 0.3% EAR DROPS is a generic product labeled by Somerset Therapeutics, LLC, priced at $0.9789 per ML under NDC 70069068701. Its NADAC has been published 84 times since Feb 26, 2025.
FDA first approved this application on Oct 15, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069068701
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA216328FDA Approved
10/15/2024
TE Code
AT
On Market Since
10/31/2024
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EAR DROPS has been published 84 times since Feb 26, 2025, and over the history we have for it it has declined 25.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9789 per ML |
|---|---|
| All-time high | $1.4174 (Jul 16, 2025) |
| All-time low | $0.9468 (May 20, 2026) |
| 52-week high | $1.2312 |
| 52-week low | $0.9468 |
| Median price | $1.1573 |
| Average price | $1.1642 |
| Largest weekly change | -8.5% (Sep 17, 2025) |
| Weeks tracked | 84 |
| Tracking since | Feb 26, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EAR DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EAR DROPS, manufactured by Somerset Therapeutics, LLC, is $0.9789 per ML (NDC 70069068701), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EAR DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EAR DROPS has declined 25.8%. It has been tracked across 84 weekly CMS publications since Feb 26, 2025.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EAR DROPS?
Since Feb 26, 2025, the NADAC for OFLOXACIN 0.3% EAR DROPS has ranged from a low of $0.9468 (May 20, 2026) to a high of $1.4174 (Jul 16, 2025), with a median of $1.1573 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EAR DROPS?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OFLOXACIN 0.3% EAR DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures OFLOXACIN 0.3% EAR DROPS?
OFLOXACIN 0.3% EAR DROPS (NDC 70069068701) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.